Effect of Taping in the Hemiplegic Patient With a Deficit of the Footbrowers
Launched by UNIVERSITY HOSPITAL, TOULOUSE · Sep 14, 2017
Trial Information
Current as of July 04, 2025
Terminated
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient with a stroke occurring in a period ranging from 15 days to a month before inclusion and presenting left or right hemiplegia.
- • Voluntary motricity of the dorsal flexors of the foot greater than or equal to 1 on the scale of Held and Pierrot Deseilligny
- • Quadriceps voluntary motor skill greater than or equal to 2 on the scale of Held and Pierrot Deseilligny
- • Informed consent of the patient.
- Exclusion Criteria:
- • - Evolutive neurological disease leading to cognitive impairment (Alzheimer's, Parkinson's, Multiple sclerosis ...)
- • Pre-stroke neurological sequelae
- • Achilles tendon elongation or tendinous transfer surgery.
- • Spasticity of the sural triceps greater than 2 on the modified Ashworth scale
- • Injection of botulinum toxin
- • Patients under guardianship, curatorships or under safeguard of justice.
- • Allergy to glue, skin lesions located on the zone of laying of the bands
- • Complex Regional Pain Symptom of the Ankle
About University Hospital, Toulouse
The University Hospital of Toulouse is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on patient-centered care, the hospital integrates cutting-edge scientific inquiry with comprehensive clinical services. Its multidisciplinary team of healthcare professionals collaborates with renowned researchers to facilitate pioneering studies across various medical fields, aiming to enhance treatment options and improve patient outcomes. As a prominent institution in the region, the University Hospital of Toulouse is committed to fostering an environment of excellence in both education and research within the healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toulouse, , France
Patients applied
Trial Officials
Aurélie MORIN
Principal Investigator
University Hospital, Toulouse
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials